Integrating medicine, engineering and business to educate early-stage researchers in cardiovascular device development

Nat Biotechnol. 2022 Oct;40(10):1528-1529. doi: 10.1038/s41587-022-01498-6.

Abstract

Device development is a burgeoning, innovative industry, yet early stage scientists have little knowledge of venture creation and the steps required to develop a device, likely contributing to the high failure rate of device technology. At present, there is no national program that provides specialty education for biomedical product development. In response to this critical problem, the Translational Pathways for Cardiovascular Devices course was developed with the goal of integrating medicine, engineering, and business education to targeted multidisciplinary early stage researchers. Pilot data show there was a greater than 300% increase in cardiac device translational practices competency; 67% of respondents indicated they planned to develop a cardiac device. The data highlight the need to develop a device development educational core to further enhance national, international and multidisciplinary innovation and collaboration in the biomedical device domain.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Commerce
  • Engineering*
  • Humans
  • Medicine*
  • Research Personnel